Business Context and Reporting Period
This Form 8-K reports on the 2024 Annual Meeting of Stockholders held by Ekso Bionics Holdings, Inc. on June 6, 2024. The filing details the voting results for five proposals submitted to security holders. The registrant is incorporated in Nevada and trades on the NASDAQ Capital Market under the symbol EKSO.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial performance data. The text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Voting Results
Of the 18,099,260 shares outstanding, 11,425,241 shares were present, constituting a quorum. All five proposals were approved by the stockholders:
- Election of Directors: Five nominees (Scott G. Davis, Mary Ann Cloyd, Corinna Lathan, Charles Li, and Deborah Lafer Scher) were elected to serve until the 2025 annual meeting.
- Equity Incentive Plan Extension: Stockholders approved extending the term of the Amended and Restated 2014 Equity Incentive Plan to April 15, 2034. The authorized share count was increased by 1,000,000 shares to a total of 4,724,286 shares.
- Executive Compensation (Say-on-Pay): An advisory vote approved the compensation of named executive officers.
- Frequency of Say-on-Pay: Stockholders voted to hold future advisory votes on executive compensation annually.
- Auditor Ratification: The appointment of WithumSmith+Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2024, was ratified.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, outlook, risks, contingencies, or unusual items. It strictly reports the outcomes of the shareholder vote.
Investor Verification Checklist
- Verify the impact of the 1,000,000 share increase in the Equity Incentive Plan on potential future dilution.
- Review the proxy statement filed on April 26, 2024, for detailed biographies of the newly elected directors and specific executive compensation figures.
- Confirm the independence and qualifications of the newly ratified auditor, WithumSmith+Brown, PC.
- Monitor the company's upcoming 10-K filing for the fiscal year ending December 31, 2024, for actual financial performance metrics.